Detection, clinical relevance and specific biological properties of disseminating tumour cells - PubMed (original) (raw)
Review
doi: 10.1038/nrc2375.
Affiliations
- PMID: 18404148
- DOI: 10.1038/nrc2375
Review
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al. Nat Rev Cancer. 2008 May.
Abstract
Most cancer deaths are caused by haematogenous metastatic spread and subsequent growth of tumour cells at distant organs. Disseminating tumour cells present in the peripheral blood and bone marrow can now be detected and characterized at the single-cell level. These cells are highly relevant to the study of the biology of early metastatic spread and provide a diagnostic source in patients with overt metastases. Here we review the evidence that disseminating tumour cells have a variety of uses for understanding tumour biology and improving cancer treatment.
Similar articles
- New technologies for the detection of circulating tumour cells.
Gerges N, Rak J, Jabado N. Gerges N, et al. Br Med Bull. 2010;94:49-64. doi: 10.1093/bmb/ldq011. Epub 2010 Apr 23. Br Med Bull. 2010. PMID: 20418405 Review. - Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN.
Wollenberg B, Walz A, Kolbow K, Pauli C, Chaubal S, Andratschke M. Wollenberg B, et al. Onkologie. 2004 Aug;27(4):358-62. doi: 10.1159/000079088. Onkologie. 2004. PMID: 15347890 - [Detection of micrometastases and circulating tumour cells using molecular biology technics in solid tumours].
Schleiermacher G, Delattre O. Schleiermacher G, et al. Bull Cancer. 2001 Jun;88(6):561-70. Bull Cancer. 2001. PMID: 11459702 French. - Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
Alunni-Fabbroni M, Sandri MT. Alunni-Fabbroni M, et al. Methods. 2010 Apr;50(4):289-97. doi: 10.1016/j.ymeth.2010.01.027. Epub 2010 Jan 29. Methods. 2010. PMID: 20116432 Review. - The clinical significance of circulating tumor cells in the peripheral blood.
Elshimali YI, Grody WW. Elshimali YI, et al. Diagn Mol Pathol. 2006 Dec;15(4):187-94. doi: 10.1097/01.pdm.0000213463.98763.b9. Diagn Mol Pathol. 2006. PMID: 17122646 Review.
Cited by
- Clinical opportunities and challenges in targeting tumour dormancy.
Hensel JA, Flaig TW, Theodorescu D. Hensel JA, et al. Nat Rev Clin Oncol. 2013 Jan;10(1):41-51. doi: 10.1038/nrclinonc.2012.207. Epub 2012 Nov 27. Nat Rev Clin Oncol. 2013. PMID: 23183631 Review. - A computational study of circulating large tumor cells traversing microvessels.
Kojić N, Milošević M, Petrović D, Isailović V, Sarioglu AF, Haber DA, Kojić M, Toner M. Kojić N, et al. Comput Biol Med. 2015 Aug;63:187-95. doi: 10.1016/j.compbiomed.2015.05.024. Epub 2015 Jun 10. Comput Biol Med. 2015. PMID: 26093786 Free PMC article. - Microfluidic cell sorter (μFCS) for on-chip capture and analysis of single cells.
Chung J, Shao H, Reiner T, Issadore D, Weissleder R, Lee H. Chung J, et al. Adv Healthc Mater. 2012 Jul;1(4):432-6. doi: 10.1002/adhm.201200046. Epub 2012 May 2. Adv Healthc Mater. 2012. PMID: 23184773 Free PMC article. - Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?
Ward MP, E Kane L, A Norris L, Mohamed BM, Kelly T, Bates M, Clarke A, Brady N, Martin CM, Brooks RD, Brooks DA, Selemidis S, Hanniffy S, Dixon EP, A O'Toole S, J O'Leary J. Ward MP, et al. Mol Cancer. 2021 Mar 31;20(1):59. doi: 10.1186/s12943-021-01347-1. Mol Cancer. 2021. PMID: 33789677 Free PMC article. Review. - Circulating tumor cells as therapy-related biomarkers in cancer patients.
Gorges TM, Pantel K. Gorges TM, et al. Cancer Immunol Immunother. 2013 May;62(5):931-9. doi: 10.1007/s00262-012-1387-1. Epub 2013 Jan 12. Cancer Immunol Immunother. 2013. PMID: 23314304 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources